Targeting inflammation in cardiometabolic disease: Icosapent ethyl modulates monocyte‐derived macrophages isolated from patients with cardiovascular disease with or without type 2 diabetes
This study will provide mechanistic insight into how IPE influences macrophage-driven inflammation in ASCVD and T2DM, informing strategies to target residual inflammatory risk in high-risk cardiometabolic populations.
Authors
- Kelvin H. Lee (ORCID: https://orcid.org/0000-0003-0908-2981)
- P. E. Squires
- M. U. Shah
- C. E. Hills
- J. K. Ward
Institutions
- University of Hull (GB)
- United Lincolnshire Hospitals NHS Trust (GB)
- University of Lincoln (GB)
Publication Details
- Journal
- Diabetic Medicine
- Published
- 2026-02-09
- DOI
- https://doi.org/10.1111/dme.70247
- Primary Topic
- Fatty Acid Research and Health
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Amarin Corporation